Trials / Completed
CompletedNCT00000447
Behavioral/Drug Therapy for Alcohol-Nicotine Dependence (Naltrexone/Nicotine Patch)
Behavioral/Pharmacological Treatments for Alcohol-Nicotine Dependence
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 200 (planned)
- Sponsor
- The University of Texas Health Science Center, Houston · Academic / Other
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
This study will develop a behavioral and drug relapse prevention program for individuals who are dependent on both alcohol and tobacco. The study's goal is to show that individuals receiving nicotine replacement therapy and naltrexone (Revia) with behavior therapy will have higher rates of abstinence from both smoking and drinking than individuals who do not receive the drug therapies. Individuals will be placed in a 12-week outpatient treatment program with followup assessments 1, 3, and 6 months after treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | naltrexone (Revia) | |
| DRUG | nicotine replacement patch |
Timeline
- Start date
- 1998-09-01
- Completion
- 2003-05-01
- First posted
- 1999-11-03
- Last updated
- 2010-10-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00000447. Inclusion in this directory is not an endorsement.